468 related articles for article (PubMed ID: 27817758)
1. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
Rodrigues R; Barber GE; Ananthakrishnan AN
Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
[TBL] [Abstract][Full Text] [Related]
2. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study.
Kunishima H; Ito K; Laurent T; Abe M
J Infect Chemother; 2018 Nov; 24(11):892-901. PubMed ID: 30190105
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
[TBL] [Abstract][Full Text] [Related]
4. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
[TBL] [Abstract][Full Text] [Related]
5. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
Zhang D; Prabhu VS; Marcella SW
Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
[TBL] [Abstract][Full Text] [Related]
6. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
Gabriel L; Beriot-Mathiot A
J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections.
Jamot S; Raghunathan V; Patel K; Kelly CR; Lim SH
Infect Control Hosp Epidemiol; 2018 Mar; 39(3):302-306. PubMed ID: 29363436
[TBL] [Abstract][Full Text] [Related]
8. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
[TBL] [Abstract][Full Text] [Related]
9. Attributable Cost of Clostridium difficile Infection in Pediatric Patients.
Mehrotra P; Jang J; Gidengil C; Sandora TJ
Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC
BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794
[TBL] [Abstract][Full Text] [Related]
11. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
[TBL] [Abstract][Full Text] [Related]
12. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection.
Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S
J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638
[TBL] [Abstract][Full Text] [Related]
14. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
[TBL] [Abstract][Full Text] [Related]
15. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
[TBL] [Abstract][Full Text] [Related]
16. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life.
Wilcox MH; Ahir H; Coia JE; Dodgson A; Hopkins S; Llewelyn MJ; Settle C; Mclain-Smith S; Marcella SW
J Antimicrob Chemother; 2017 Sep; 72(9):2647-2656. PubMed ID: 28633368
[TBL] [Abstract][Full Text] [Related]
17. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
18.
Asempa TE; Nicolau DP
Clin Interv Aging; 2017; 12():1799-1809. PubMed ID: 29123385
[TBL] [Abstract][Full Text] [Related]
19. The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study.
Nanwa N; Kwong JC; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Sander B
Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1068-78. PubMed ID: 27322606
[TBL] [Abstract][Full Text] [Related]
20. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.
Yu H; Baser O; Wang L
BMC Geriatr; 2016 Nov; 16(1):193. PubMed ID: 27884118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]